Eva Chalas

4.9k citations
89 papers · 3.8k · 2 hit papers · h-index 23

Impact in

Papers in

    • Endometrial and Cervical Cancer Treatments 16
    • Uterine Myomas and Treatments 12
    • Gynecological conditions and treatments 5
    • Ovarian cancer diagnosis and treatment 17
    • Endometriosis Research and Treatment 7

Eva Chalas

83 papers receiving 3.6k citations

Eva Chalas's Hit Papers

Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial 2021 · 319 citations
3190+3+6Years since publication50010001.5k

Peers

Eva Chalas
Comparison fields: 5 of 114
  • Reproductive Medicine 1.1k
  • Obstetrics and Gynecology 589
  • Oncology 1.8k
  • Cancer Research 227
  • Genetics 442
Replace Rodney Paul Rocconi with:
Rodney Paul Rocconi United States
Mihaela C. Cristea United States
Charles Alexander Leath United States
Creighton L. Edwards United States
Jacobus Pfisterer Germany
Barbara Schmalfeldt Germany
Michael T McHale United States
Cor Doede de Kroon Netherlands
Thomas C. Krivak United States
Marta Ann Crispens United States
Eva Chalas relative to Rodney Paul Rocconi United States Rodney Paul Rocconi's profile →
Citations per field
00.5×1.5×2.0×
Rodney Paul Rocconi · 1×
Citations per year

Countries citing papers authored by Eva Chalas

Since Specialization
Citations

This map shows the geographic impact of Eva Chalas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Chalas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Chalas more than expected).

Fields of papers citing papers by Eva Chalas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Chalas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Chalas. The network helps show where Eva Chalas may publish in the future.

Co-authors

The 25 scholars most cited alongside Eva Chalas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eva Chalas Line = papers co-authored together Eva Chalas links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 89 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
Hit paper breakdown →
20171562
2
Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial
Hit paper breakdown →
2021319
3 2002278
4 2020131
5 201088
6 199087
7 200584
8 201882
9 201274
10 199674
11 199171
12
Ovarian carcinoma arising in atypical endometriosis.
199064
13 199850
14 201550
15 199946
16 199642
17 199640
18 201636
19
Microglandular hyperplasia of the uterine cervix.
198533
20 200431

About Eva Chalas

Eva Chalas is a scholar working on Obstetrics and Gynecology, Reproductive Medicine, Surgery, Oncology and Pulmonary and Respiratory Medicine, having authored 89 papers that have together received 3.8k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (17 papers), Endometrial and Cervical Cancer Treatments (16 papers), Uterine Myomas and Treatments (12 papers), Endometriosis Research and Treatment (7 papers), BRCA gene mutations in cancer (7 papers), Enhanced Recovery After Surgery (5 papers), Gynecological conditions and treatments (5 papers) and PARP inhibition in cancer therapy (5 papers). The work is most often cited by research in Reproductive Medicine (1.1k citations), Obstetrics and Gynecology (589 citations), Oncology (1.8k citations), Cancer Research (227 citations) and Genetics (442 citations). Eva Chalas has collaborated with scholars based in United States, Italy and Croatia. Frequent co-authors include Michael L. Pearl, John C. Chumas, William J. Mann, Ute Martha Moll, Fidel A. Valea, Neda Slade, Susan H. Erster, Christine Sansome, Troy W. Joseph and John L. Wagner. Their work appears in journals such as Gynecologic Oncology, Obstetrics and Gynecology, Obstetrical & Gynecological Survey, Journal of Minimally Invasive Gynecology and American Journal of Obstetrics and Gynecology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact